wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36880037-A821BAA3-FA17-4900-9FAD-DE09151D6880
Q36880037-A821BAA3-FA17-4900-9FAD-DE09151D6880
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36880037-A821BAA3-FA17-4900-9FAD-DE09151D6880
Randomized phase II trial of cyclophosphamide and the oral poly (ADP-ribose) polymerase inhibitor veliparib in patients with recurrent, advanced triple-negative breast cancer
P2860
Q36880037-A821BAA3-FA17-4900-9FAD-DE09151D6880
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36880037-A821BAA3-FA17-4900-9FAD-DE09151D6880
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7afc62be19e8d437cd8a077fcda13d958d949c8b
P2860
A phase II evaluation of the potent, highly selective PARP inhibitor veliparib in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer in patients who carry a germline BRCA1 or BRCA2 mutation - An